fda bpc 157 compounding category 2 list Peptide Update: Removals Explained Category 1 vs. Category 2.

Category 1 vs. Category 2. The FDA's peptide update, explained. Category 2 peptides are on the FDA's difficult to compound list, which effectively blocks licensed pharmacies from producing them. Category 1 means The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step FDA Panel to Review 7 Peptides in July (2026) FDA's Overreach on Compounded Peptides

SKU: 85237390647 · From clintoncounty708.com